Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Nextcure Inc (NXTC)

Nextcure Inc (NXTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Nextcure Inc 9000 VIRGINIA MANOR ROAD SUITE 200 BELTSVILLE MD 20705 USA

www.nextcure.com Employees: 82 P: 240-399-4900

Description:

NextCure Inc. is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing immunomedicines to treat cancer and other immune-related diseases. The company's product candidate consists of NC318 and NC410 which are in clinical stage. NextCure Inc. is based in Beltsville, Maryland.

Key Statistics

Overview:

Market Capitalization, $K 36,129
Enterprise Value, $K 23,049
Shares Outstanding, K 28,007
Annual Sales, $ 0 K
Annual Net Income, $ -62,720 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -11,540 K
EBIT, $ -63,080 K
EBITDA, $ -60,150 K
60-Month Beta 0.80
% of Insider Shareholders 13.30%
% of Institutional Shareholders 42.65%
Float, K 24,282
% Float 86.70%
Short Volume Ratio 0.21

Growth:

1-Year Return 2.34%
3-Year Return -78.24%
5-Year Return -97.26%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.41 on 11/07/24
Next Earnings Date N/A
Earnings Per Share ttm -2.09
EPS Growth vs. Prev Qtr 25.45%
EPS Growth vs. Prev Year 19.61%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

NXTC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -62.50%
Return-on-Assets % -53.67%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.48
Book Value/Share 2.70
Interest Coverage -2.18
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar